Emergency physicians make treatment decisions about positive urine cultures that result after patients are discharged from the emergency department (ED). The Infectious Diseases Society of America (IDSA) incorporates both symptoms and laboratory findings into the diagnosis of a urinary tract infection (UTI). Typical symptoms include dysuria, urinary frequency, urgency, suprapubic pain or tenderness, and flank pain, while confirmation of a UTI requires a positive urine culture with ≥100,000 colony-forming units (CFU) per milliliter of a single organism [
1]. Although many cases involve patients who presented with clear symptoms of a UTI, a substantial proportion involve atypical presentations (e.g., confusion or a fall in an older patient) or patients without symptoms plausibly attributable to a UTI. Such positive culture results are considered asymptomatic bacteriuria (ASB) [
1].
The IDSA recommends against antibiotic treatment for nearly all cases of asymptomatic bacteriuria other than in pregnant patients. Despite these recommendations, prescribers treat an average of 45% of ASB cases with antibiotics, according to a recent meta-analysis [
2]. However, this and a more recent study addressing ASB in the emergency setting use conservative definitions, excluding cases with vague symptoms unless those symptoms are clearly attributable to another cause [
2,
3]. These scenarios, which emergency physicians frequently face, have been understudied. Our earlier paper examining the binary decision to treat with antibiotics demonstrated frequent deviation from IDSA recommendations both in these scenarios and in cases that fit a conservative ASB definition [
4]. As a follow-up, this study aims to clarify how emergency physicians manage ASB by examining antibiotic selection and treatment duration following a positive culture result in ED patients who are asymptomatic or present with symptoms atypical for UTI.
We surveyed emergency medicine physicians based at an academic tertiary care medical center and its affiliated hospital network, which includes six community hospitals. The study used a cross-sectional design. An electronic questionnaire was emailed to all emergency physicians across the network and addressed nine common scenarios encountered when following up a positive urine culture, including several involving asymptomatic or minimally symptomatic bacteriuria. These scenarios were selected based on existing IDSA guidelines and to reflect the range of emergency practice [
1,
5–
10]. ASB was defined as one or more bacterial species growing in the urine at ≥100,000 CFU/mL in the absence of signs or symptoms of a UTI [
1]. Responses were collected over a 3-month period.
The survey was distributed to 305 emergency physicians, with 120 responses received, yielding a response rate of 39.3%. Of these respondents, 49 (40.8%) worked in academic medical centers with affiliated emergency medicine residency programs, 45 (37.5%) in large community hospitals (greater than 40,000 visits per year), and 26 (21.7%) in small community hospitals (less than 40,000 visits per year). Survey participants included 14 residents (11.7%), 33 attendings (27.5%) with less than 5 years out of training, 23 attendings (19.2%) with 5–9 years out, 37 attendings (30.8%) with 10–20 years out, and 13 attendings (10.8%) with more than 20 years out (
Table 1).
Cephalexin was the most commonly prescribed antibiotic (selected 344 times, 46.9%), followed by cefpodoxime (162 times, 22.1%) and nitrofurantoin (144 times, 19.6%) (
Table 2,
Fig. 1). The only scenarios in which cephalexin was not the most common choice were the asymptomatic female patient (scenario 1), in which nitrofurantoin was most frequently selected, and the asymptomatic post–kidney transplant male patient (scenario 9), in which cefpodoxime was most common. Overall, ciprofloxacin was the least commonly prescribed agent. In five of the nine scenarios, none of the 120 emergency physicians selected ciprofloxacin. The only scenarios in which it was not the least commonly chosen antibiotic were the asymptomatic male patients (scenarios 3 and 7) and the asymptomatic post–kidney transplant patient (scenario 9).
Overall, a 7-day course of antibiotics was most commonly selected (338 times, 46.2%), followed by 5 days (240 times, 32.8%) and 10 days (122 times, 16.7%) (
Table 3,
Fig. 2). A 3-day course was rarely selected across all scenarios. Clinical scenarios in which a 5-day course was more frequently chosen included the 27-year-old asymptomatic woman (scenario 1), the 75-year-old postmenopausal asymptomatic woman (scenario 2), the 24-year-old pregnant woman (scenario 4), and the 43-year-old asymptomatic woman with diabetes (scenario 8). A 10-day course was selected more often in all scenarios involving a male patient, including the 32-year-old asymptomatic man (scenario 3), the 76-year-old man with confusion after a fall (scenario 6), the 62-year-old asymptomatic man with an indwelling Foley catheter (scenario 7), and the 52-year-old man post–kidney transplant (scenario 9).
The emergency physicians surveyed demonstrated considerable variability in both the type and duration of antibiotics prescribed. Across all scenarios, most physicians selected either a 5- or 7-day treatment course, and the most common antibiotic choices were cefpodoxime and cephalexin. In the single scenario with clear IDSA recommendations for treatment, ASB in a pregnant woman, physicians largely followed established guidelines; 89.9% (107 of 119) selected a 5- or 7-day antibiotic course, which corresponds to the IDSA recommendation of 4 to 7 days of therapy [
1]. In this scenario, all physicians selected either nitrofurantoin or a β-lactam antibiotic (cefpodoxime or cephalexin), again matching IDSA guidance [
1].
Variability in practice patterns appeared most pronounced in scenarios involving vague symptoms that could plausibly be related to a UTI. For example, for the 76-year-old man with confusion and a fall (scenario 6), respondents selected all five antibiotic options, and treatment durations ranged between 5 and 10 days, indicating no consensus. Similarly, multiple respondents treating ASB in a kidney transplant patient selected various antibiotics and durations, reflecting the limited evidence available to guide decisions in these cases [
11]. The frequent selection of cephalexin was particularly noteworthy because it generally requires dosing four times daily, which can make adherence more difficult.
For ASB scenarios without symptoms suggestive of UTI, antibiotic selections often diverged from current IDSA guidelines for cystitis treatment. The latest IDSA recommendations for women with cystitis advise a 5-day course of nitrofurantoin or a 3-day course of trimethoprim-sulfamethoxazole as first-line therapy, reserving β-lactams for situations in which first-line agents cannot be used [
12]. Although physicians predominantly chose nitrofurantoin when treating a young woman with bacteriuria and no symptoms, they tended to favor β-lactams when the patient had diabetes or was older.
Physicians generally prescribed longer antibiotic courses for male patients, consistent with the traditional view that male UTIs are “complicated” because of anatomic considerations. However, recent studies challenge this assumption and suggest that 7-day courses may be adequate for men [
13–
15].
Ciprofloxacin and trimethoprim-sulfamethoxazole were rarely selected across all clinical scenarios. This pattern may reflect concerns about adverse events associated with fluoroquinolones and high community resistance rates to trimethoprim-sulfamethoxazole [
16].
The substantial variability observed in this follow-up study highlights the challenges emergency physicians face when balancing UTI management with antibiotic stewardship. Because patients are often lost to follow-up, physicians may favor broader-spectrum or longer-duration therapy even when evidence suggests such practices are unnecessary. Although patients with classic UTI symptoms and positive cultures require treatment to prevent complications such as pyelonephritis or urosepsis, overtreatment of ASB persists as a significant problem [
6]. Inappropriate antibiotic use contributes to resistance at both individual and community levels [
1,
7]. Emergency physicians must therefore weigh risks and benefits carefully, tailoring choices about antibiotic type and duration to each clinical situation.
Overtreatment partly arises from a culture of excessive urinalysis and culture ordering in ED settings, driven by concerns about missing occult infection. One study of an academic emergency department found that urinalyses were ordered for one quarter of patients presenting with chest pain or headache [
17]. Efforts to reduce mistreatment include requiring a second order for a culture after an initial urinalysis, canceling low-risk culture orders, and limiting reflex culture practices [
18–
21]. Some departments have also incorporated pharmacist review of cultures to guide antibiotic choice and duration and to decrease unnecessary treatment. As a result, studies have shown improved adherence to IDSA guidelines and, in one case, successful discontinuation of antibiotics for ASB [
22–
24]. However, the extent to which such initiatives are widely implemented is unclear, and inappropriate treatment of ASB, as demonstrated in our studies, likely remains common.
Limitations of this study include its relatively small sample size from a single network of emergency physicians, which may reduce generalizability. Nonetheless, the sample encompassed a wide range of physicians, from residents to those with more than 20 years of experience, as well as individuals practicing in small community, large community, and academic hospitals, and physicians currently practicing in other healthcare settings. Although the survey response rate was modest, the diversity of the network likely provides a reasonable cross-section of emergency physicians. Response bias is also possible because participation was voluntary, and self-reported practices may not perfectly reflect actual behavior.
In conclusion, this follow-up study demonstrates substantial variation in emergency physicians’ choices regarding antibiotic selection and duration. Most physicians treat positive urine cultures for 5 or 7 days and most frequently prescribe cephalexin. While timely treatment is necessary to prevent progression and complications, unnecessary antibiotic use can cause harm both to individual patients and to the broader community. Further research is needed to better inform treatment decisions for bacteriuria in patients with vague or atypical symptoms and to clarify the factors influencing management choices.
NOTES
-
Ethics statement
This study was exempted from an institutional review board approval because it was considered a quality assurance project, and participation was voluntary. All participants provided online informed consent before beginning the survey.
-
Author contributions
Conceptualization: SAG, JE; Data curation: AD, NC; Formal analysis: all authors; Investigation: SAG, JE, AD, NC; Methodology: SAG, JE, AD, NC; Project administration: SAG; Resources: SAG, JE; Software: NC, AD, SAG; Supervision: SAG, JE; Validation: SAG, JE; Visualization: SAG, JE, AD, CM; Writing–original draft: AD; Writing–review & editing: all authors. All authors read and approved the final manuscript.
-
Conflicts of interest
The authors have no conflicts of interest to declare.
-
Funding
The authors received no financial support for this study.
-
Data availability
Data analyzed this study are available from the corresponding author upon reasonable request.
Fig. 1.Antibiotic selection by clinical scenario: (1) a 27-year-old asymptomatic nonpregnant woman; (2) a 75-year-old asymptomatic postmenopausal woman; (3) a 32-year-old asymptomatic man; (4) a 24-year-old asymptomatic pregnant woman; (5) an 88-year-old asymptomatic woman after a fall without urinary symptoms; (6) a 76-year-old man with confusion after a fall without urinary symptoms; (7) a 62-year-old asymptomatic man with an indwelling Foley catheter; (8) a 43-year-old asymptomatic woman with diabetes; and (9) a 52-year-old asymptomatic man post–kidney transplant.
Fig. 2.Treatment duration by clinical scenario: (1) a 27-year-old asymptomatic nonpregnant woman; (2) a 75-year-old asymptomatic postmenopausal woman; (3) a 32-year-old asymptomatic man; (4) a 24-year-old asymptomatic pregnant woman; (5) an 88-year-old asymptomatic woman after a fall without urinary symptoms; (6) a 76-year-old man with confusion after a fall without urinary symptoms; (7) a 62-year-old asymptomatic man with an indwelling Foley catheter; (8) a 43-year-old asymptomatic woman with diabetes; and (9) a 52-year-old asymptomatic man post–kidney transplant.
Table 1.Demographic characteristics of the respondents (n=120)
Table 1.
|
Characteristic |
No. of respondents (%) |
|
Practice setting |
|
|
Academic medical center |
49 (40.8) |
|
Large community hospital |
45 (37.5) |
|
Small community hospital |
26 (21.7) |
|
No. of years out of training |
|
|
Resident |
14 (11.7) |
|
<5 |
33 (27.5) |
|
5–9 |
23 (19.2) |
|
10–20 |
37 (30.8) |
|
>20 |
13 (10.8) |
Table 2.Number of respondents selecting each antibiotic by scenario
Table 2.
|
Clinical scenario |
Cefpodoxime |
Cephalexin |
Ciprofloxacin |
Nitrofurantoin |
Trimethoprim-sulfamethoxazole |
|
1 (n=41) |
1 (2.4) |
13 (31.7) |
0 (0) |
25 (61.0) |
2 (4.9) |
|
2 (n=60) |
6 (10.0) |
36 (60.0) |
0 (0) |
16 (26.7) |
2 (3.3) |
|
3 (n=120) |
28 (23.3) |
50 (41.7) |
15 (12.5) |
9 (7.5) |
18 (15.0) |
|
4 (n=119) |
5 (4.2) |
70 (58.8) |
0 (0) |
44 (37.0) |
0 (0) |
|
5 (n=76) |
15 (19.7) |
41 (53.9) |
0 (0) |
17 (22.4) |
3 (3.9) |
|
6 (n=116) |
40 (34.5) |
55 (47.4) |
4 (3.4) |
8 (6.9) |
9 (7.8) |
|
7 (n=34) |
12 (35.3) |
13 (38.2) |
3 (8.8) |
1 (2.9) |
5 (14.7) |
|
8 (n=56) |
7 (12.5) |
26 (46.4) |
0 (0) |
19 (33.9) |
4 (7.1) |
|
9 (n=111) |
48 (43.2) |
40 (36.0) |
7 (6.3) |
5 (4.5) |
11 (9.9) |
|
All scenarios (n=733) |
162 (22.1) |
344 (46.9) |
29 (4.0) |
144 (19.6) |
54 (7.4) |
Table 3.Number of respondents selecting each duration of treatment by clinical scenario
Table 3.
|
Clinical scenario |
Duration of treatment (day)
|
|
3 |
5 |
7 |
10 |
|
1 (n=41) |
9 (22.0) |
25 (61.0) |
7 (17.1) |
0 (0) |
|
2 (n=60) |
5 (8.3) |
31 (51.7) |
24 (40.0) |
0 (0) |
|
3 (n=119) |
2 (1.7) |
16 (13.4) |
60 (50.4) |
41 (34.5) |
|
4 (n=119) |
8 (6.7) |
54 (45.4) |
53 (44.5) |
4 (3.4) |
|
5 (n=76) |
2 (2.6) |
37 (48.7) |
37 (48.7) |
0 (0) |
|
6 (n=116) |
0 (0) |
22 (19.0) |
65 (56.0) |
29 (25.0) |
|
7 (n=34) |
0 (0) |
3 (8.8) |
18 (52.9) |
13 (38.2) |
|
8 (n=56) |
2 (3.6) |
40 (71.4) |
13 (23.2) |
1 (1.8) |
|
9 (n=111) |
4 (3.6) |
12 (10.8) |
61 (55.0) |
34 (30.6) |
|
All scenarios (n=732) |
32 (4.4) |
240 (32.8) |
338 (46.2) |
122 (16.7) |
REFERENCES
- 1. Nicolle LE, Gupta K, Bradley SF, et al. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. Clin Infect Dis 2019;68:e83-110.
- 2. Flokas ME, Andreatos N, Alevizakos M, Kalbasi A, Onur P, Mylonakis E. Inappropriate management of asymptomatic patients with positive urine cultures: a systematic review and meta-analysis. Open Forum Infect Dis 2017;4:ofx207.
- 3. Veillette JJ, Waters CD, Gelman SS, et al. Antibiotic prescribing for adult bacteriuria and pyuria in community hospital emergency departments. Am J Emerg Med 2021;40:1-5.
- 4. Castañeda NR, Doodlesack A, Fyfe W, Edlow J, Grossman SA. The data and the reality: urine cultures and emergency medicine physicians. Intern Emerg Med 2022;17:2349-55.
- 5. Trautner BW, Grigoryan L. Approach to a positive urine culture in a patient without urinary symptoms. Infect Dis Clin North Am 2014;28:15-31.
- 6. Gupta K. Acute simple cystitis in female adults. In: UpToDate [Internet]. Wolters Kluwer; [updated 2026 Jan 9; cited 2020 May 20]. Available from: https://www.uptodate.cn/contents/acute-simple-cystitis-in-female-adults
- 7. Mody L, Juthani-Mehta M. Urinary tract infections in older women: a clinical review. JAMA 2014;311:844-54.
- 8. Colgan R, Williams M. Diagnosis and treatment of acute uncomplicated cystitis. Am Fam Physician 2011;84:771-6.
- 9. Matuszkiewicz-Rowińska J, Małyszko J, Wieliczko M. Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems. Arch Med Sci 2015;11:67-77.
- 10. Cortes-Penfield NW, Trautner BW, Jump RL. Urinary tract infection and asymptomatic bacteriuria in older adults. Infect Dis Clin North Am 2017;31:673-88.
- 11. Goldman JD, Julian K. Urinary tract infections in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019;33:e13507.
- 12. Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52:e103-20.
- 13. Drekonja DM, Rector TS, Cutting A, Johnson JR. Urinary tract infection in male veterans: treatment patterns and outcomes. JAMA Intern Med 2013;173:62-8.
- 14. Drekonja DM, Trautner B, Amundson C, Kuskowski M, Johnson JR. Effect of 7 vs 14 days of antibiotic therapy on resolution of symptoms among afebrile men with urinary tract infection: a randomized clinical trial. JAMA 2021;326:324-31.
- 15. Germanos GJ, Trautner BW, Zoorob RJ, et al. No clinical benefit to treating male urinary tract infection longer than seven days: an outpatient database study. Open Forum Infect Dis 2019;6:ofz216.
- 16. Umarje SP, Alexander CG, Cohen AJ. Ambulatory fluoroquinolone use in the United States, 2015-2019. Open Forum Infect Dis 2021;8:ofab538.
- 17. Stagg A, Lutz H, Kirpalaney S, et al. Impact of two-step urine culture ordering in the emergency department: a time series analysis. BMJ Qual Saf 2018;27:140-7.
- 18. Patel HP. The abnormal urinalysis. Pediatr Clin North Am 2006;53:325-37.
- 19. Jones CW, Culbreath KD, Mehrotra A, Gilligan PH. Reflect urine culture cancellation in the emergency department. J Emerg Med 2014;46:71-6.
- 20. Munigala S, Rojek R, Wood H, et al. Effect of changing urine testing orderables and clinician order sets on inpatient urine culture testing: analysis from a large academic medical center. Infect Control Hosp Epidemiol 2019;40:281-6.
- 21. Randolph AG, Reder L, Englund JA. Risk of bacterial infection in previously healthy respiratory syncytial virus-infected young children admitted to the intensive care unit. Pediatr Infect Dis J 2004;23:990-4.
- 22. Giruzzi ME, Tawwater JC, Grelle JL. Evaluation of antibiotic utilization in an emergency department after implementation of an antimicrobial stewardship pharmacist culture review service. Hosp Pharm 2020;55:261-7.
- 23. Zhang X, Rowan N, Pflugeisen BM, Alajbegovic S. Urine culture guided antibiotic interventions: a pharmacist driven antimicrobial stewardship effort in the ED. Am J Emerg Med 2017;35:594-8.
- 24. Gupta K. Acute simple cystitis in male adults. In: UpToDate [Internet]. Wolters Kluwer; updated 2025 Jan 23; [cited 2023 May 20]. Available from: https://www.uptodate.cn/contents/acute-simple-cystitis-in-male-adults
Citations
Citations to this article as recorded by
